![June Almenoff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 90 121 $ in data 31/05/2026
June Sherie Almenoff is currently an Independent Director at Tenax Therapeutics, Inc. since 2021 and an Independent Director at Actinium Pharmaceuticals, Inc. since 2024.
Former positions include President, CEO, Director & Chief Medical Officer at Furiex Pharmaceuticals, Inc. from 2010 to 2014; Executive Chairman at RDD Pharma Ltd. from 2015 to 2018; Independent Non-Executive Director at TiGenix NV from 2016 to 2018; Director at Kurome Therapeutics, Inc. from 2020 to 2021; Independent Director at Ohr Pharmaceutical, Inc. from 2013 to 2019; Independent Director at Brainstorm Cell Therapeutics, Inc. from 2017 to 2023; Independent Director at Avalo Therapeutics, Inc. from 2021 to 2025; Vice President-Clinical Safety Organization at GlaxoSmithKline LLC from 1997 to 2010; Chief Operating & Medical Officer at 9 Meters Biopharma, Inc. in 2018; and Chief Medical Officer at RedHill Biopharma Ltd. Membership in the Infectious Diseases Society of America is noted.
Education includes undergraduate studies at Smith College and a doctorate from Icahn School of Medicine at Mount Sinai.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 17/06/2025 | 4.167 ( 0,01% ) | 66 464 $ | 31/05/2026 | |
| 08/04/2026 | 1.993 ( 0,01% ) | 23 657 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| TENAX THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 25/02/2021 |
| ACTINIUM PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/11/2024 |
| Società | Posizione | Fine |
|---|---|---|
| AVALO THERAPEUTICS, INC. | Direttore/Membro del Consiglio | 01/10/2025 |
| BRAINSTORM CELL THERAPEUTICS INC. | Direttore/Membro del Consiglio | 01/12/2023 |
Kurome Therapeutics, Inc.
 Kurome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies that target cancer cells | Direttore/Membro del Consiglio | 01/01/2021 |
Ohr Pharmaceutical, Inc.
 Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pharmaceuticals for the treatment of serious and unmet medical needs | Direttore/Membro del Consiglio | 12/07/2019 |
| 9 METERS BIOPHARMA, INC. | Direttore operativo | 16/11/2018 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 15 |
|---|---|
Tenax Therapeutics, Inc.
 Tenax Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes pharmaceutical therapeutic products | Health Technology |
Brainstorm Cell Therapeutics, Inc.
 Brainstorm Cell Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company, which develops innovative adult stem cell therapeutic products | Health Technology |
TiGenix NV
 TiGenix NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company focused on developing and commercializing novel therapeutic | Health Technology |
Furiex Pharmaceuticals, Inc.
 Furiex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a drug development collaboration company | Health Technology |
Smith College
 Smith College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Icahn School of Medicine at Mount Sinai
 Icahn School of Medicine at Mount Sinai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Infectious Diseases Society of America
 Infectious Diseases Society of America Miscellaneous Commercial ServicesCommercial Services Operates as a medical association representing physicians, scientists, and other healthcare professionals | Commercial Services |
RDD Pharma Ltd.
 RDD Pharma Ltd. Medical SpecialtiesHealth Technology Develops pharmacological treatments for diseases of the anorectal region | Health Technology |
Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops novel pharmaceuticals for the treatment of serious and unmet medical needs | Health Technology |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology Engages in research and development, manufacturing of respiratory, immunology, oncology and infectious disease medicines and vaccines | Health Technology |
RedHill Biopharma Ltd.
 RedHill Biopharma Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provides GI, infectious diseases, medical countermeasures and oncology services | Health Technology |
Avalo Therapeutics, Inc.
 Avalo Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics for patients with unmet clinical need in immunology and rare genetic diseases | Health Technology |
Actinium Pharmaceuticals, Inc.
 Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
9 Meters Biopharma, Inc.
 9 Meters Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals for people with rare digestive diseases and gastrointestinal conditions | Health Technology |
Kurome Therapeutics, Inc.
Kurome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies that target cancer cells | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
